NR1H4 and inflammatory bowel disease: While IBD and HF exhibit opposite alterations in bile acid profiles, with primary dominant in IBD and secondary dominant in HF, both conditions converge on disrupted bile acid receptor signaling and downstream inflammatory and fibrotic pathways.